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Abstract
Constraint-based models of metabolism are a widely used framework for predicting flux distributions in genome-scale
biochemical networks. The number of published methods for integration of transcriptomic data into constraint-based
models has been rapidly increasing. So far the predictive capability of these methods has not been critically evaluated and
compared. This work presents a survey of recently published methods that use transcript levels to try to improve metabolic
flux predictions either by generating flux distributions or by creating context-specific models. A subset of these methods is
then systematically evaluated using published data from three different case studies in E. coli and S. cerevisiae. The flux
predictions made by different methods using transcriptomic data are compared against experimentally determined
extracellular and intracellular fluxes (from 13C-labeling data). The sensitivity of the results to method-specific parameters is
also evaluated, as well as their robustness to noise in the data. The results show that none of the methods outperforms the
others for all cases. Also, it is observed that for many conditions, the predictions obtained by simple flux balance analysis
using growth maximization and parsimony criteria are as good or better than those obtained using methods that
incorporate transcriptomic data. We further discuss the differences in the mathematical formulation of the methods, and
their relation to the results we have obtained, as well as the connection to the underlying biological principles of metabolic
regulation.
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Introduction
During the past years, there have been successful applications of
computational modeling of cellular metabolism in biotechnology
[1,2]. Different mathematical formalisms have been proposed for
this goal, with kinetic and constraint-based models among the
most widely adopted ones [3]. Whereas kinetic modeling requires
extensive experimental data for determining the rate laws and
kinetic parameters of biochemical reactions, constraint-based
modeling mainly requires knowledge of the stoichiometry of the
metabolic network. This information can be obtained from
annotated genome sequences and metabolic pathway databases,
making this approach quite suitable for the reconstruction of
metabolic models at the genome scale. Constraint-based models
describe the range of steady-state flux distributions of a metabolic
network, using the so-called flux balance analysis (FBA) approach
[4]. The simplicity and scalability of this approach, coupled with
the advances in genome sequencing, has made constraint-based
modeling a popular framework within the scientific community,
and led to an explosion in the number of genome-scale metabolic
reconstructions currently available [5]. These reconstructions
range from microbes to higher organisms, and have been used
for myriad applications, including the prediction of cellular
phenotypes, design of microbial cell factories, studies of evolution,
and model-driven discovery of novel drug targets [2,6].
In order to study the effects of environmental perturbations or
genetic manipulations on cellular metabolism, one can measure
changes at the transcript, protein, metabolite, and flux levels.
However, analyzing the coordinated behavior of the different
biological processes requires the integration of this information
under one common framework. Although flux measurements can
be easily integrated into constraint-based models [7], there is no
straightforward way to integrate other sources of data. For that
reason, new methods to integrate different kinds of omics data into
constraint-based models are being developed [8].
The advancements in high-throughput sequencing methods
have increased the speed and decreased the cost of DNA and RNA
sequencing [9]. Therefore, it is no surprise that most constraint-
based methods for integration of experimental data have focused
on the transcriptome. Some of these methods have already been
covered in recent reviews [8,10,11]. However, they have not been
critically and quantitatively evaluated using the same validation
data. Furthermore, new methods are being developed at a fast
pace (Fig. 1) and common method validation and comparison
methodologies are needed to assess these methods.
Novel methods in computational biology are usually evaluated
with dedicated case studies and data sets in the publications that
introduce them. However, it is difficult to systematically evaluate
and compare methods as the cases and data sets used in different
publications are usually different. For this reason, there has been
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increased attention recently on performing dedicated studies that
compare multiple methods using common cases and data sets [12].
Such studies can reveal differences in similar approaches and help
in identifying strengths and weaknesses of particular approaches
[13,14]. These types of method comparison studies also play an
important role in ensuring the reproducibility of computational
research as they verify that published method implementations
function as intended with novel data sets [15].
This work presents a comprehensive survey and a critical
evaluation of the methods for integrating transcriptomics data to
genome-scale metabolic models published thus far, with the
purpose of guiding a careful methods selection and discussing
limitations of the existing methods. In the spirit of reproducible
research, we also aim to make it easier to evaluate new
methods developed in the future by making all of our code
and preprocessed datasets publicly available to the scientific
community.
Survey of methods
The methods presented in this survey tend to fall into one of two
categories. One encompasses all the methods that use transcript
levels in order to improve the prediction of metabolic flux
distributions. On the other hand are the methods for creating
tissue (or context) specific models from more generic organism-
specific models. A typical example is the creation of models for
different kinds of human cells using the global human metabolic
reconstruction, which can be used for the study of tissue specific
diseases [16,17]. Note that some methods fall into both categories,
i.e. they return both a context-specific model and a metabolic flux
distribution for the complete model consistent with the gene
expression data. At the implementation level, the methods differ
mainly in the way they use the expression data, by integrating
either discrete or continuous expression levels, and by using
absolute values for a single condition, or relative expression levels
between different conditions (Fig. 2).
A˚kesson-04 (2004). One of the earliest approaches to
integrate gene expression data into constraint-based models was
proposed by A˚kesson and co-workers with the purpose of
improving flux predictions [18]. In this very simple approach,
some reactions are deactivated, by constraining their flux to zero,
if their associated genes are expressed at low levels. Using this
method, the authors observed improved predictions in the
metabolic flux distributions of S. cerevisiae.
GIMME (2008). Gene Inactivity Moderated by Metabolism
and Expression (GIMME), uses gene expression data to build
context-specific models [19]. This method finds a flux distribution
that is consistent with a given biological objective and that
minimizes the utilization of reactions classified as inactive,
weighted by the difference between their expression level and a
given threshold. The authors used this method to model adaptive
evolution in E. coli strains, and to create tissue-specific human cell
models. A recent extension of the method, GIM3E, extends the
previous method in order to force a minimum turnover rate for
experimentally measured metabolites [20].
Shlomi–08/iMAT (2008). The integrative metabolic analysis
tool (iMAT) [16] implements a method proposed by Shlomi and
coworkers for finding tissue-specific activity in the human
metabolic reconstruction [21]. In this case, gene expression is
used to divide reactions into two groups: highly and lowly
expressed. It then finds a flux distribution that maximizes the
consistency with this classification. It has the advantage of not
requiring the definition of a biological objective, facilitating the
analysis of biological systems, such as multi-cellular organisms,
where this definition is not so clear.
Figure 1. Publications per year. Number of publications of methods
for integration of transcriptomic data into constraint-based metabolic
models: publications per year (bars); cumulative sum (lines).
doi:10.1371/journal.pcbi.1003580.g001
Figure 2. Methods overview. Classification of the methods
regarding how they treat the gene expression levels (discrete vs
continuous, absolute vs relative) and their intended functionality
regarding flux prediction, model building or both.
doi:10.1371/journal.pcbi.1003580.g002
Author Summary
Constraint-based modeling has become one of the most
successful approaches for modeling large-scale biochem-
ical networks. There are nowadays hundreds of genome-
scale reconstructions of metabolic networks available for a
wide variety of organisms ranging from bacteria to human
cells. One of the limitations of the constraint-based
approach is that it describes the cellular phenotype simply
in terms of biochemical reaction rates, in a way that is
disconnected from other biological processes such as
genetic regulation. In order to overcome this limitation,
different approaches for integration of gene expression
data into constraint-based models have been developed
during the past few years. However, all the methods
developed so far have only been tested using isolated case
studies. In this work, we elaborate a detailed survey of
these methods, and perform a critical and quantitative
evaluation of a selected subset of methods, using
experimental datasets that include different organisms
and conditions. This study highlights some of the current
limitations in many of these methods, and reveals that no
method published so far systematically outperforms the
others.
Transcriptomic Data in Constraint-Based Modeling
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Moxley–09 (2009). Moxley and coworkers developed a
method that predicts flux variation as a function of variation in
gene expression [22]. It uses a pathway-specific parameter called
‘‘metabolite interaction density’’, defined as the ratio of the
number of metabolite-enzyme interactions to that of the total
reaction enzymes in a pathway. Its calculation requires a
topological reconstruction of all possible metabolite-enzyme
interactions. The rationale for this method is that the correlation
between changes in gene expression and reaction levels is likely to
be higher in pathways with smaller interaction density, corre-
sponding to increased degree of post-transcriptional regulation.
The authors observed a significant increase in the correlation
between measured and predicted fluxes after accounting for the
interaction density parameter in their formulation.
E–Flux (2009). E–Flux is a method that directly maps
normalized gene expression levels into flux bound constraints
using a ‘‘pipe capacity’’ analogy [23]. The rationale behind this
method is that, although enzyme activities are not directly
determined by their respective transcript levels, the latter can be
used as an approximate upper bound for the reaction rates. In this
case, the expression level of each gene is normalized by the
maximum gene expression level across all genes. In a follow up
study, the authors implement a similar formulation that, instead,
normalizes each gene expression level by the maximum expression
level of the same gene across multiple experiments [24].
PROM (2010). Probabilistic regulation of metabolism
(PROM) is a method for integration of regulatory and metabolic
networks [25]. Given abundant gene expression data measured
under multiple conditions, it generates a probabilistic model for
the gene regulatory network, which is integrated with a constraint-
based metabolic model by setting the flux bounds proportional to
the associated probabilities. In principle, this approach can be
used to integrate gene expression data directly into the metabolic
model, using the fraction of times a gene is active in a set of
samples. However, this requires an experimental data set with a
large number of measurements per condition.
MADE (2011). Metabolic Adjustment by Differential Expres-
sion (MADE) aims to overcome the problem of selecting arbitrary
thresholds by comparing measurements across multiple conditions
[26]. It uses the statistical significance between changes in gene
expression levels across sequential conditions to find consistent
series of activation/deactivation patterns. The solutions for all
conditions are then solved simultaneously in order to maximize the
agreement with the predicted patterns.
tFBA (2011). Transcriptionally controlled FBA (tFBA) follows
the same principles as MADE, albeit with a different formulation
[27]. In this case, measurements across multiple conditions are
also used, but they do not need to be from a time course. Up/
down regulation events are included in the problem formulation,
and the optimization problem consists of finding a suitable set of
flux distributions across all conditions that minimizes the number
of constraint violations.
INIT (2012). The Integrative Network Inference for Tissues
algorithm (INIT) is a method for building tissue-specific models
from genome-scale reconstructions [28]. It was designed to use
proteomic data from the Human Protein Atlas, but can also use
transcriptomic data. It maximizes the activation of certain
reactions based on a qualitative confidence score while minimizing
the utilization of reactions associated with absent proteins. One of
the novel aspects of this method is the relaxation of the steady-state
condition to allow a small net accumulation rate for internal
metabolites. If there is evidence for the presence of a metabolite,
this accumulation is imposed in order to prevent the removal of
the reactions necessary for its synthesis.
Lee–12 (2012). Lee and coworkers proposed a method that
integrates absolute gene expression data directly into the objective
function of a constraint-based model, instead of manipulating the
flux constraints [29]. The biological objective function is replaced
by a function that minimizes the distance between the flux
distribution and the gene expression data. The authors performed
a comparison of this method against FBA, GIMME and iMAT,
revealing a better accuracy in the prediction of secretion fluxes for
S. cerevisiae under two growth conditions.
Fang–12 (2012). The method developed by Fang and co–
workers is based on the hypothesis that the flux distribution for a
reference condition can be calculated with existing methods, and
that the differential gene expression between a perturbed and
reference condition can be used to predict the flux distribution for
the perturbed state [30]. The method recalculates the flux
distribution for the perturbed state, imposing flux bounds based
on the relative gene expression between the two conditions. One of
the novel aspects in this method is to allow small variations in the
biomass composition for the perturbed condition, in order to
account for the biomass variability that can occur under different
growth conditions.
RELATCH (2012). RELATive CHange (RELATCH) is a
two-step method that uses flux and gene expression data from a
reference state to predict metabolic responses in a genetically or
environmentally perturbed state [31]. In a first step, transcriptomic
and fluxomic data are used to predict a flux distribution and
corresponding enzyme contributions for the reference state. The
second step determines the flux distribution for a perturbed state
that minimizes the adjustment to the reference distribution, and is
consistent with the estimated enzyme contributions. Although this
approach was designed to estimate flux distributions in perturbed
states for which no expression data is available, the first step can,
in principle, be used to predict flux distributions based on gene
expression data for any given condition (we will refer to this
variant as RELATCH*).
TEAM (2012). Temporal Expression-based Analysis of Me-
tabolism (TEAM) is a method that combines dynamic Flux
Balance Analysis (dFBA) [32] and GIMME to predict time-course
flux profiles based on temporal gene expression patterns [33]. It
recalculates the flux distribution at each time step using the
respective gene expression levels. It also offers some improvements
over the original GIMME formulation, such as using gene-specific
thresholds and using flux sum minimization to select among
alternative optimal solutions.
AdaM (2012). Adaptation of Metabolism (AdaM) is a method
for integration of temporal gene expression data [34]. For each
time point, it finds a minimal functional network consistent with
the differential expression pattern. However, rather than calculat-
ing a flux distribution for each time point, it computes the set of
elementary flux modes (EFMs) [35] for the subnetwork. The time-
course pattern for each reaction is then represented by the fraction
of EFMs containing the reaction at each time point.
GX–FBA (2012). Gene-expression FBA (GX–FBA) is a flux
prediction method that incorporates gene expression data into flux
balance analysis [36]. It shares with E–Flux and Lee–12 the ability
to directly use continuous expression levels. However, it uses
differential gene expression between a perturbed and a reference
condition rather than absolute expression values. It calculates a
flux distribution for the reference condition, and then uses the
relative expression levels to define flux constraints and a new
objective function for the perturbed state.
mCADRE (2012). Metabolic Context-specificity Assessed by
Deterministic Reaction Evaluation (mCADRE) is a context-
specific model building method [17]. Unlike similar methods such
Transcriptomic Data in Constraint-Based Modeling
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as the Model Building Algorithm (MBA) [37] that only uses
transcript and protein data as evidence for metabolic functionality,
mCADRE uses the gene expression levels and the network
topology to calculate connectivity-based evidence scores for all
reactions in a model. These scores are used to determine which
reactions should be removed from the generic model to create a
context-specific model.
FCGs (2013). Flux-coupled genes (FCGs) is a method
developed under the hypothesis that, although gene expression
and flux levels are not always correlated, there might exist a subset
of genes whose expression levels are consistent with the respective
fluxes [38]. Since the identification of the FCGs requires
transcriptome and fluxome data for the respective reactions under
multiple conditions, the authors could only identify FCGs for the
central carbon metabolism. Once identified, FCGs can be used to
test new conditions by setting the upper bound of reactions
associated with down-regulated FCGs to a fraction of the
predicted flux. Furthermore, a sampling approach is applied in
order to account for imperfect correlation between flux and gene
expression.
EXAMO (2013). The EXploration of Alternative Metabolic
Optima (EXAMO) method for context-specific model building
extends the iMAT approach by searching for multiple optima with
the same agreement score [39]. The frequency of reactions in
these multiple optima is calculated and used to build a context-
specific model with MBA. A separate method is provided for flux
estimation using the context-specific model, which minimizes the
overall sum of fluxes while enforcing that a minimal flux is carried
by the high frequency reactions. With this method the authors
were able to predict the Crabtree effect in yeast cells growing in
excess glucose.
Results
In order to compare the predictive capability of the different
methods, we tested their predictions using experimental datasets
taken from the literature. From the initial survey of methods, we
evaluated those that provide an implementation and that can be
directly used for flux prediction. Note that although some of the
methods not evaluated did provide an implementation, it was
specific to a particular case study and not readily usable for
general-purpose application.
In their original publications the methods have been validated
using diverse sources of information and experimental data,
usually not including actual fluxomics data (Table S1). Also, these
publications rarely compare the proposed method with existing
methods. The evaluation we performed requires a dataset with
both transcriptomic and fluxomic data (ideally exchange rates as
well as intracellular fluxes obtained by 13C-labeling) obtained
using the same exact conditions for the same strain. However
multi-omics studies that contain these two kinds of data are not
common to find even for widely studied microbes such as E. coli
and S. cerevisiae. A compilation of suitable multi-omic datasets is
presented as supplementary material (Table S2). From these
candidate datasets we selected the three that had intracellular flux
profiles and transcriptome data: Ishii et al [40] and Holm et al [41]
datasets for E. coli; and Rintala et al dataset for yeast [42].
In this study we attempt to address two main questions: First,
how well can the methods predict the cellular physiology as well as
the intracellular fluxes; Second, how does the integration of the
measured physiological parameters (growth and secretion rates)
influence the prediction of the intracellular flux distribution. Also,
in order to understand how the integration of gene expression data
can improve phenotype prediction, we compare the results with
those obtained by standard FBA simulation. To avoid the typical
degeneracy of FBA solutions, the parsimonious version of FBA
(pFBA) was used. This approach finds a flux distribution with
minimum absolute flux values among the alternative optima,
assuming that the cell attempts to achieve its objective (here
assumed to be maximization of biomass production) while
allocating the minimum amount of resources.
Case study: E. coli (Ishii)
This case study uses a comprehensive omics dataset published
by Ishii et al [40]. The experimental setup consists of E. coli strains
growing aerobically in a chemostat at a dilution rate of 0.2 h21.
The different experiments include variations of the dilution rate
(from 0.1 to 0.7 h21), and several single-gene knockout mutants
growing at the reference dilution rate. For this dataset, the gene
expression data is limited to the central carbon metabolism and is
measured by microarray analysis.
The assessed methods were applied to a genome-scale metabolic
reconstruction of E. coli [43], to predict the complete phenotype
(growth, secretion and intracellular fluxes) from the gene
expression data, given only the measured glucose and oxygen
uptake rates as constraints. Figure 3a shows the error distribution
for the different methods (see Methods section for a description of
the normalized error calculation). It can be observed that the
median error for each method is higher than that of pFBA.
Furthermore, many of the methods also have a higher variation in
the error distribution compared to pFBA.
In order to understand how the phenotype predictions vary
across the different methods, we analyze in detail a particular case,
namely the experiment at the highest dilution rate (0.7 h21). This
is a typical case where FBA simulations are less accurate, since the
assumption of growth yield maximization no longer holds true due
to overflow metabolism. This is one of the experiments where
pFBA gives a higher prediction error, and a likely scenario where
alternative methods, such as those studied herein, will be most
useful.
The measured and predicted flux phenotypes are shown in
Figure 4. It can be observed that, in most cases, the results differ
significantly from the measured values. Since the oxygen uptake
rate is constrained, pFBA is able to predict the secretion of
fermentation products, namely lactate and acetate. However, it
predicts higher values than the experimental ones. All the methods
predict some level of lactate production, although not all were able
to predict the production of acetate (iMAT, E–Flux, Lee–12). The
residual amounts of CO2 and pyruvate produced were either not
predicted by most of the methods, or overestimated by some
methods (GIMME, iMAT, GX–FBA). Lee–12 incorrectly pre-
dicted a large production of ethanol. None of the methods
predicted the production of succinate, and all correctly predicted
the absence of formate production.
Regarding growth rate prediction, there are essentially two
cases. The methods that maximize biomass production (pFBA, E–
Flux) and the methods that impose some predefined threshold of
biomass production (GIMME, MADE), predict values close to the
maximum theoretical level. On the other hand, methods that do
not impose any constraints regarding the growth rate simply
predict no growth at all (iMAT, Lee–12, RELATCH*, GX–FBA).
In order to understand the influence of imposing experimental
measurement constraints on the predictive ability of the methods,
all the simulations were repeated using the complete set of
measured uptake, growth and secretion rates as constraints
(Fig. 3d). As expected, a decrease in the prediction error can be
observed for many of the methods, with a higher impact on those
that do not make assumptions regarding the growth rate (iMAT,
Transcriptomic Data in Constraint-Based Modeling
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RELATCH*, GX–FBA). On the other hand, Lee–12 exhibited an
unexpected significant deterioration in performance when con-
straints were added.
A comparison between the predicted and measured fluxes
across conditions for all the methods is given as supplementary
material (Fig. S1). The experimental conditions are sorted by
increasing error obtained by pFBA. Although there seems to be no
correlation between the prediction errors across conditions, it can
be observed that some of the methods exhibit a few biases towards
systematically predicting higher or lower fluxes than experimental
measurements for particular reactions.
Finally, we test whether integration of proteomic data (also
included in this dataset) results in more accurate predictions than
the use of gene expression data (Fig. S4). Despite some differences,
there is no improvement in predictive ability when proteomics
data is used instead of transcriptomics data.
Case study: E. coli (Holm)
This case study uses a dataset from Holm et al [41], whose
experimental setup consists of E. coli strains growing aerobically in
batch cultures. The study compares the phenotype of the wild-type
strain with two over-expression mutants, nox (NADH oxidase) and
atpAGD (F1-ATPase), with the goal of understanding global
transcriptional responses to lowered levels of NADH and ATP.
The dataset contains gene expression data measured at the
genome scale using microarray analysis and 13C-flux data.
The methods were tested using the same metabolic model as in
the previous case study. In this dataset glucose uptake is the only
measured uptake rate. The error distributions are shown in
Figure 3b. Again, it can be observed that all methods show a
higher median prediction error than pFBA. In this case, GX–FBA
exhibits a much higher variation across conditions compared to
the other methods.
The predicted phenotypes for the over-expression mutants are
analyzed in more detail (Fig. 5). Unlike gene knockouts or gene
insertions, over-expression targets do not change the topology of
the metabolic network. Therefore, this is a typical case where the
flux-balance formulation is insufficient to predict phenotypic
changes. In fact, it can be observed that pFBA does not predict the
decrease in growth rate and the increase in acetate secretion that
characterizes these mutant strains. Only E–Flux was able to
predict acetate production in both conditions, although in the first
Figure 3. Prediction error for all methods. Distribution of the normalized prediction error for each method across multiple conditions for the
different datasets. Each box plot represents the distribution of the prediction error for all conditions in one dataset. Two scenarios are evaluated:
prediction of the complete metabolic phenotype (growth, secretion and intracellular fluxes) from measured uptake rates (a–c); and prediction of the
intracellular fluxes from the measured physiology (growth, uptake and secretion rates) (d–f).
doi:10.1371/journal.pcbi.1003580.g003
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case the quantitative prediction is incorrect. As in the previous case
study, only the methods that define a biomass objective or
requirement predict positive growth rates. In this case E–Flux
successfully predicted the growth rate to be below the theoretical
maximum.
The impact of including the measured growth and secretion
rates as constraints was also measured (Fig. 3f). As expected, most
of the median error values decreased. Again, this impact is more
significant for the methods that do not make any assumptions
regarding the growth rate. A significant decrease in variation is
observed for GX–FBA.
A comparison between the predicted and measured fluxes for all
conditions is given as supplementary material (Fig. S2). It is
interesting to observe that, especially in the cases of pFBA and
E–Flux, the biases in flux prediction towards certain reactions are
the same as observed in the previous case study.
Case study: S. cerevisiae
This case study uses a dataset from Rintala et al [42], whose
experimental setup consists of S. cerevisiae strains growing in a
glucose-limited chemostat at a dilution rate of 0.1 h21 with
different oxygenation levels. These include intermediate levels
from fully anaerobic to fully aerobic. The dataset contains
genome-wide gene expression data. Fluxomic data for the same
conditions could be obtained from a separate publication [44].
The assessed methods were used to integrate the gene
expression data into a recent genome-scale metabolic reconstruc-
tion of S. cerevisiae [45]. Measured oxygen and glucose uptake rates
Figure 4. Physiology prediction (Ishii). Predicted and measured physiology: secretion rates (mmol/gDW/h) and growth rate (h21), for the
D= 0.7 h21 experimental condition from the Ishii dataset.
doi:10.1371/journal.pcbi.1003580.g004
Figure 5. Physiology prediction (Holm). Predicted and measured physiology: acetate secretion rate (mmol/gDW/h) and growth rate (h21) for the
two over expression mutants (NADP oxidase and ATPase) from the Holm dataset.
doi:10.1371/journal.pcbi.1003580.g005
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were set as constraints. The error distribution for the different
methods is shown in Figure 3c. As already observed in the previous
case studies, all of the methods (with the exception of E–Flux)
present a median prediction error above that of pFBA.
We analyze in more detail the results for the two extreme
conditions, complete aerobiosis and complete anaerobiosis (Fig. 6).
For the aerobic case, the growth rate is very close to the maximum
theoretical value, and no fermentation products are secreted. This
is the typical case where the underlying assumptions of FBA are
valid, as can be observed by the accuracy of the predictions.
However, some of the methods incorrectly predict the secretion of
some fermentation products. Under anaerobic conditions, the
strain produces ethanol at high rates, and also a small amount of
glycerol. All methods were able to predict ethanol production at
rates similar to the experimental values, with the exception of GX–
FBA that predicted a lower level of ethanol secretion accompanied
with secretion of acetate and glycerol. GIMME and Lee–12 also
incorrectly predicted the formation of acetate. On the other hand,
Lee–12 predicted the glycerol secretion rate more accurately.
As in the previous case studies, we analyze the impact of
including the complete physiological measurements (uptake,
secretion and growth rates) as constraints (Fig. 3f). A decrease in
the median prediction error is observed for most methods.
Furthermore, a significant decrease in variability is observed for
RELATCH* and GX–FBA. The comparison between the
predicted and measured fluxes for all conditions is given as
supplementary material (Fig. S3). In this case, very few systematic
biases can be observed.
Finally, we tested whether integration of proteomic data (also
included in this dataset) results in more accurate predictions than
the use of gene expression data (Fig. S4). Since the number of
transcripts whose levels could be measured is one order of
magnitude above the number of proteins whose levels were
measured, we recalculated the prediction error from transcript
data using the subset of genes that match measured protein levels.
Using only a subset of the transcriptomic data results in a small
decrease in the variability of the prediction error, without affecting
the median error. Furthermore, with the exception of E–Flux,
there are no significant changes in the flux predictions when
proteomics data is used instead of transcriptomics data.
Sensitivity and robustness analysis
Three of the methods evaluated, namely GIMME, iMAT and
MADE are parameterized, which makes the results presented so
far dependent on the particular choice of the parameter
configuration. Therefore, the sensitivity of the prediction error
with respect to the parameter values was analyzed. For each case,
one parameter was varied at a time while the others remained
fixed (see Methods). In order to ensure that the results are not
dependent on the case study, the analysis was performed for two
datasets (Holm and Rintala).
The results show that for most parameters the variation is not
monotonic with respect to the parameter value, and that the
variance for one particular value can be larger than the average
variation across the whole parameter range (Figs. S5, S6).
Nevertheless, some trends can be observed. In general, higher
cutoff thresholds for the gene expression data seem to be preferred,
leading to the deactivation of more genes. A lower flux activation
threshold is preferable for iMAT, and higher values of the
required fraction of the biological objective seem to be favorable
for GIMME and MADE. All these choices lead to parsimony in
enzyme usage and maximization of the biological objective, which
are the same principles used in pFBA. This is not surprising,
considering that pFBA had in general better predictive power than
other methods for all the case studies presented herein.
Figure 6. Physiology prediction (Rintala). Predicted and measured physiology: secretion rates (mmol/gDW/h) and growth rate (h21) for two
extreme conditions (full aerobiosis, full anaerobiosis) from the Rintala dataset.
doi:10.1371/journal.pcbi.1003580.g006
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Finally, we tested the robustness of all the methods towards
noise in the data (Fig. S7). The level of noise was gradually
increased by a weighted combination of the original data with
random data (see Methods). By gradually varying the noise weight
from 0 to 1, the methods were given increasing levels of noise,
including completely random data at the last step. This allows
studying the robustness of the methods towards small levels of
noise, as well as possible biases in the flux predictions in response
to randomized data. The analysis was performed using the
anaerobic condition from the Rintala dataset. This is a test case
where all the methods have low error levels to begin with.
One would expect a smooth increase in the average prediction
error with increasing noise level as an indicator of robustness. This
increase in the error should also be accompanied by a gradual
increase in the variance in flux predictions (made using different
noisy transcript patterns generated at the same level of noise) as an
indicator of the absence of systematic bias in flux predictions.
However, only E–Flux exhibited this pattern. GIMME and Lee–
12 show a gradual increase in the variance, although the average
prediction error is the same for the original and the random data.
MADE and iMAT show small changes in the average prediction
error, coupled with a mostly constant level of variance. GX–FBA
shows a smooth increase in the average prediction error, coupled
with a sharp increase in variance, and fails to compute for very
high levels of noise. RELATCH* shows an apparent constant level
of the prediction error, with an increasing variation that is many
orders of magnitude lower compared to the other methods. Hence
the solution is biased regardless of the gene expression levels.
Discussion
In this work we surveyed a wide variety of methods that
integrate gene expression data into constraint-based models of
metabolism. The publication rate of these types of methods seems
to be rapidly increasing, which shows that the solution to this
problem is far from trivial.
In general, these methods fall into one of two categories. They
have been used to improve the prediction of metabolic flux
distributions based on transcript levels, a useful tool for metabolic
engineering of microbial cell factories [29,31]. Also, they have
been used to generate tissue (or context) specific models based on
gene expression patterns, with potential applications in the study
of multi-cellular organisms [16,17,28]. Since these are two distinct
goals, we opted to focus this work on the evaluation of the former
application. We believe that the latter application should be the
subject of a dedicated study. As it was observed (see discussion
below), the integration of transcript levels did not significantly
improve flux predictions in a consistent manner. It is likely that the
integration of gene expression data will prove itself more
promising for the latter application. In the analysis of multi-
cellular organisms, the biological principles commonly applied for
microbes (such as maximization of growth rate) do not apply, and
the definition of a tissue-specific objective is often unclear. Hence,
the formulation of an objective function based on gene or protein
expression data may provide a suitable alternative. Furthermore, a
better correlation between gene expression and metabolic fluxes
should be expected in multicellular organisms, due to the complete
activation/deactivation of metabolic pathways in a tissue-specific
fashion.
From the initial survey, seven methods were evaluated in detail,
and their predictive ability was compared to that of FBA (in its
parsimonious version). The experimental datasets used were
selected in order to provide a variety of test scenarios, including
a prokaryotic (E. coli) and an eukaryotic organism (S. cerevisiae). The
experimental conditions included batch and chemostat fermenta-
tions, aerobic and anaerobic growth, as well as single gene
deletions and over-expression mutants.
All the methods have a lower overall predictive capability
compared to pFBA. At first sight this might indicate that the
integration of gene expression data is hampering, rather than
improving, the prediction of flux distributions. Given the variety of
case studies it is unlikely that the selection of experiments was
coincidentally favorable towards the pFBA approach. However,
our evaluation could still be biased due to the fact that it is only
possible to compare the simulated fluxes with intracellular flux
measurements (from 13C-labeling) for the central carbon metab-
olism. It is known that the central metabolic pathways are more
heavily regulated at post-transcriptional levels [46–48], hence
transcript levels are in general not suitable for estimation of fluxes
of the central carbon metabolism. It is likely that transcript profiles
are better estimators of flux profiles of pathways that carry smaller
fluxes. However, these fluxes will not be quantitatively correctly
predicted if the central carbon flux profile is not correctly
predicted as well.
In all the methods reviewed herein, transcript levels are used as
surrogates for enzyme expression levels. Hence, if proteomics data
are available, the latter could be used as well. In principle, protein
levels should provide a more accurate snapshot of metabolism
than transcript levels. However, we did not observe any
improvements in the predictions when we used proteomic rather
than transcriptomic data. This seems to indicate that the major
obstacle in predicting fluxes from gene expression is the lack of
correlation between protein levels and reaction rates.
There are multiple other possible reasons for the relatively poor
predictive ability of many of the methods tested here. First, some
of the methods were originally designed to make qualitative
predictions and their ability to predict fluxes quantitatively was
never assessed. Second, most methods do not try to incorporate
other biological principles that may govern the cellular response
such as minimization of overall flux magnitudes. It is known that
in many cases transcriptional regulation acts as a mere modulatory
factor in response to global cellular adjustments [49]. Finally, it is
possible that some of the tested methods are better suited for
particular conditions or organisms. Further studies could reveal
why and when is gene expression a good predictor of metabolic
flux distributions.
Since none of the methods evaluated in detail performs
consistently better or worse than the other methods, we will not
make any recommendations in favor or against any particular
method. Users of these methods should perform a careful
evaluation of the meaningfulness of the results for their particular
applications. We further discuss in more detail some of the major
differences found within the formulation of these methods, in
order to guide the selection of a suitable subset of methods for a
given application.
Discrete vs continuous levels
One of the main features distinguishing the surveyed methods is
the discretization of the gene expression data. It would seem
preferable to make use of the continuous expression data in order
not to lose the fine-grained data on the individual gene expression
levels. Also, this avoids the definition of arbitrary threshold
parameters. However, it is not possible to conclude that the
methods that use continuous expression data (E–Flux, Lee–12,
RELATCH*, GX–FBA) provide more accurate flux predictions
than the ones that discretize the expression levels (GIMME,
iMAT, MADE).
Transcriptomic Data in Constraint-Based Modeling
PLOS Computational Biology | www.ploscompbiol.org 8 April 2014 | Volume 10 | Issue 4 | e1003580
Discretization also presents a few advantages, such as robustness
to noise in the data, seamless integration with the logic-based gene-
protein-reaction (GPR) associations, and avoiding data normali-
zation issues. Furthermore, coarse-graining the gene expression
data reduces the reliance on a direct proportionality between the
fluxes and the transcript levels.
Absolute vs relative expression
Another major distinction between the surveyed methods is the
choice between using absolute gene expression levels for one
condition, or using differential gene expression between two or
more conditions. One of the limitations of using absolute
expression levels is the lack of proportionality between transcript
and flux levels. A recent review from Hoppe highlights the
multiple steps between gene expression and reaction rates [50].
Although some level of correlation can be observed between
mRNA and protein levels, these are not directly proportional due
to differences in translation, degradation rates, and post-transla-
tional modifications. Furthermore, enzyme concentrations do not
necessarily reflect enzyme activity levels, as enzyme turnover
numbers (kcat) can vary by several orders of magnitude. Finally,
metabolite concentrations, enzyme kinetics, and network level
effects can influence the reaction flux as well.
Altogether it seems that enforcing a correspondence between
absolute transcript and flux levels does not reflect the underlying
biochemical mechanisms. In that sense, accounting for relative
expression changes as an indicator of the intended flux reconfig-
uration may provide a more meaningful description. However, the
methods that use relative expression levels (MADE and GX–FBA),
did not generally give more accurate flux predictions.
Biological objective formulation
Another distinction among the presented methods is the
utilization of a biological objective function. The mathematical
definition of a biological objective is the key step that transforms a
metabolic network reconstruction into a model that can simulate the
cellular phenotype. The maximization of growth yield, determined
from the cellular biomass composition, has been a commonly
assumed objective for microbial organisms. Although the validity of
this assumption has been experimentally confirmed under some
conditions [51], there are cases (such as overflow metabolism) where
this assumption is not valid. Also, it has been shown that the biomass
composition can vary across different experimental conditions [52].
Furthermore, in the case of multicellular organisms it is not trivial to
define a biological objective.
All of the methods evaluated, with the exception of E–Flux,
replace the biological objective function with a function that relies
on the gene expression data. Nevertheless, some of these methods
still use the original objective to define a minimum growth
requirement constraint (GIMME, MADE) or to calculate a
reference flux distribution (GX–FBA). Methods that do not make
any assumptions regarding a biological objective (iMAT, Lee–12
and RELATCH*) should be suitable for a larger scope of
organisms and experimental conditions. However, these methods
incorrectly predicted a zero growth rate in all cases, with the
exception of RELATCH* for the yeast case study.
In order to evaluate the effect of imposing a biological objective
on all methods, we repeated all the tests, adding a minimum
growth rate constraint, corresponding to 90% of the maximum
theoretical growth rate, to all simulations (Fig. S8). We observed
that the average error decreased for all the methods that do not
impose any restrictions on the growth rate otherwise (iMAT, Lee–
12, RELATCH*, GX–FBA). This decrease is similar to that
observed by adding the experimental growth and secretion rates as
constraints. Therefore, in the absence of experimental measure-
ment, the imposition of constraints related to assumed cellular
objectives may still be necessary for accurate flux predictions.
Conclusions
Despite the high number of proposed methods, the prediction of
flux levels from gene expression data is far from being solved.
Although some of the methods evaluated give reasonable
predictions under certain conditions, there is no universal method
that performs well under all scenarios. Regardless of the
mathematical formulation proposed to address the problem, the
mapping of transcripts to fluxes is intrinsically hampered by the
fact that gene expression levels do not necessarily reflect flux levels,
which are systemic properties of the cellular metabolism.
Nonetheless, the transcriptome should provide cues to guide the
determination of the correct phenotype among the space of
solutions that results from the large number of degrees of freedom
in metabolic networks.
It has been proposed that the metabolic phenotype of microbial
cells results from a trade-off between optimality and flexibility
towards adaptation [53]. The optimality principles can be further
decomposed into three distinct goals: growth yield, energy (ATP)
yield, and parsimonious use of metabolic reactions. Hence, there
are fewer inherent degrees of freedom in metabolism than the ones
given by the network topology. Our study showed that growth
yield and parsimony alone could be better predictors of metabolic
fluxes than the transcriptome for most experimental sets. The ideal
formulation to combine gene expression with fundamental
biological principles governing metabolic flux distributions is yet
to be found. This may require the integration of approaches that
consider the interplay between transcripts and other metabolic
components, by combining multiple omics data [20,54] and
kinetic parameters [55,56] into constraint-based models. Alterna-
tively, careful measurement of physiological parameters and
intracellular fluxes coupled with separate analysis of transcript
and flux patterns may be the most suitable strategy to uncover the
principles of metabolic regulation [57]. These types of data can
also be used to parameterize next generation of whole-cell models
that explicitly represent proteins and transcripts in addition to
metabolic fluxes [58,59]
Finally, we would like to acknowledge the authors who
published their source code with the respective articles. We would
like to reiterate the importance of providing published methods in
a usable format, a fundamental step for reproducible research
[15]. With this in mind, all the scripts, datasets, and results
generated from this work are freely available at: https://github.
com/cdanielmachado/transcript2flux.
Methods
Model setup
The simulations for the E. coli and S. cerevisiae case studies were
performed using, respectively, the iAF1260 and iTO977 genome-
scale models [43,45]. For all simulations, any constraints given in the
original models were discarded and (depending on the test scenario)
overridden with experimental values from the respective datasets.
Methods setup
All method-specific configuration details are given in the
following. All methods evaluated in this study have available
implementations in MATLAB (The Mathworks; Natick, MA,
USA). These were tested using MATLAB R2012b with Gurobi
Optimizer 5.5 (Gurobi Optimization, Inc.) running on a 1.7 GHz
Intel Core i5 processor.
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pFBA. FBA simulations were performed using the available
implementation in the COBRA Toolbox [60]. In all cases, the
target objective was set to biomass production. To avoid the well-
known degeneracy problem in FBA solutions [61] the option to
minimize the Manhattan norm of the flux distribution was selected
(according to the principle of parsimonious enzyme usage [62]).
Note that when the growth rate is given as constraint, the result is
simply the minimal flux distribution that complies with the
imposed constraints. For simulation of gene deletions, the
respective genes were deleted prior to simulation.
GIMME. The GIMME implementation in the COBRA
Toolbox was used. However, this implementation discretizes the
gene expression levels, which cannot then be used as weights in the
objective function. This was changed to use continuous values as
in the original publication [19]. GIMME takes two parameters:
the gene expression cutoff value, which was set to the 25th
percentile of the given expression data (this option was also
adopted in the comparison done in [29]); and the required fraction
of the original objective value, which was set to 90% of the
maximum growth rate as in the original publication. Note that
when the growth rate is given as a constraint, the latter parameter
has no effect.
iMAT. The iMAT implementation in the COBRA Toolbox
was used. However, this implementation does not use the tri-valued
logic used in the original formulation. Therefore, this was changed
to mapping scheme described in the original publication [21]. This
method takes 3 parameters: the high and low expression thresholds,
which were set to the 75th and 25th percentile of the given
expression data (same as used in [29]); and the flux activation
threshold, which was set to 1 as in the original publication.
MADE. An implementation of MADE is provided with the
original publication. MADE integrates relative gene expression
data for a series of sequential experiments into one large MILP
formulation. This can create computationally intractable problems
if the number of experiments is too large. Also, most datasets used
in this study do not represent sequential experiments. Therefore,
each experiment was individually coupled with a given reference
condition. (Note that the requirement of sequential experiments is
relaxed in a later implementation in the TIGER toolbox [63].)
Similarly to GIMME, MADE also takes as parameter the required
fraction of the original objective value, which was likewise set at
90%. If available, MADE can use p-values associated with gene
expression changes to weight the respective objective coefficients.
In this case, unit weighting was used.
E–Flux. Although the E–Flux publication does not offer
an implementation, this method is simply an FBA problem with
adjusted flux bounds. The rules for mapping gene expression to
flux bounds were implemented as described in the original
publication [23]. Note that the flux distribution obtained with
E–Flux is adimensional. In order to compare it with experimental
flux data, the resulting distributions were scaled by the given
glucose uptake rates. For this method, exchange rate
constraints are ignored, otherwise the solution space becomes
infeasible.
Lee–12. An implementation for this method is provided with
the original publication. Although the original formulation
compares flux and gene expression values directly, in the
implementation provided they are properly normalized to
adimensional units. We followed the option taken by the authors
to normalize the flux distribution by the glucose uptake rate, and
the gene expression vector by the expression levels of the glucose
transporters.
RELATCH. An implementation for RELATCH is provided
with the original publication. This method provides two routines:
the first uses gene expression data to calculate a flux distribution
for a reference state; the second uses the reference state without
additional expression data to calculate the flux distribution for a
perturbed state. In this case, only the first routine was used (here
referred to as RELATCH*). RELATCH uses the gene expression
data directly in the objective formulation without any normaliza-
tion. This makes the results dependent in the particular choice of
units for the expression vector. Therefore, the expression vectors
were divided by their mean prior to computation.
GX–FBA. An implementation for GX–FBA is provided with
the original publication. This method uses flux variability analysis
(FVA) [61] to calculate a reference flux distribution to be used for
each perturbed state. Since this is a very computationally
expensive step, it was pre-computed and passed as argument to
all method invocations in order to speed up computation.
Evaluation
Experimental data. Due to experimental error and differ-
ences in the models used in the 13C-labeling experiments, some of
the experimental flux distributions do not lie precisely within the
solution space of the genome-scale models used in this study. Since
this would cause a systematic error in the evaluation of all
methods, the experimental measurements were adjusted to the
respective model by determining the feasible flux distribution with
the smallest Euclidean distance to the original values.
GPR mapping. For the methods that use continuous gene
expression, the expression levels were mapped from genes to
reactions using the gene-protein-reaction (GPR) association rules
in the models. In each case, the mapping was performed as
described in the respective publication. In general, the expression
level of reactions catalyzed by enzyme complexes (and operator) is
set to the minimum expression level of the associated genes,
and the expression level of reactions catalyzed by isozymes (or
operator) is set to either the maximum or the sum of the
expression levels of the associated genes. In order to deal with
missing gene measurements, we opted to simplify the formula,
removing the respective gene, rather than using an arbitrary
expression value.
Removal of futile cycles. Most of the methods evaluated
herein are prone to degenerate solutions due to the existence of
futile cycles. This problem is avoided in the parsimonious version
of FBA, but it is in general not avoidable in the other methods
without altering their formulation. Given that this degeneracy can
affect the evaluation results, all simulation results were post-
processed in order to remove futile cycles. This done in a simple
procedure where the set of reactions that participate in futile cycles
are identified, and their absolute flux value is minimized, while the
fluxes of all other reactions remain fixed.
Error measurement. For each simulation, the results were
compared to the experimental measurements. The set of compared
reactions include the intracellular fluxes for central carbon
metabolism, the growth rate, and the secretion rates (the exact
number of reactions can vary for the different datasets). The error of
the estimation is given by the normalized Euclidean distance:
e~
DDvexp{vsimDD
DDvexpDD
where vexp is the vector of flux measurements, and vsim are the
simulated values. This error metric is proportional to the summed
square error (SSE) divided by the magnitude of the original flux
vector, which facilitates the comparison across conditions. For a
series of evaluations for the same method, the averaged error is
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given by the mean of the error for all experiments (failed
computations are excluded).
Sensitivity analysis. Each parameter for GIMME, iMAT
andMADEwas varied independently, while the others remained fix
at the default value described earlier. The required fraction of the
biological objective for GIMME and MADE was varied linearly
from 0 to 1. The flux activation threshold of iMAT varied from 0.1
to 10 in log-scale. The gene expression thresholds for GIMME and
iMAT were defined in terms of the percentile of the given
expression data, in order to make the results independent of the
given units. The expression threshold for GIMME varied between
the 0th and 100th percentile. For iMAT the low expression
threshold varied from the 0th to the 75th percentile, whereas the
high expression threshold varied from the 25th to the 100th
percentile. For each range, a total of 20 equally spaced values were
evaluated for the multiple experiments on each dataset.
Robustness analysis. All the methods were analyzed regard-
ing their robustness to noise in the data. The noisy data was
generated as follows. For a given experimental condition, the gene
expression vector (x) was randomly shuffled in order to generate a
random expression vector (r) that follows the same distribution as the
original data. The noisy expression data (y) is given by:
y~xzl(r{x), l[½0,1:
By varying the l parameter it is possible to vary between
intermediate noise levels that range from the original data (l=0)
to completely random data (l=1). For each test, l is varied by 10
equally spaced steps and, for each step, a total of 100 evaluations are
performed and the average prediction error is measured.
Supporting Information
Figure S1 Individual flux predictions (Ishii). Difference
between predicted and measured fluxes (mmol/gDW/h) for all the
evaluated methods, across all conditions from the Ishii dataset for
E. coli. All the conditions are sorted by increasing error of pFBA
simulation. The error distribution is individually scaled for each
method. Missing columns represent failed computations.
(TIF)
Figure S2 Individual flux predictions (Holm). Difference
between predicted and measured fluxes (mmol/gDW/h) for all the
evaluated methods, across all conditions from the Holm dataset for
E. coli. All the conditions are sorted by increasing error of pFBA
simulation. The error distribution is individually scaled for each
method. Missing columns represent failed computations.
(TIF)
Figure S3 Individual flux predictions (Rintala). Differ-
ence between predicted and measured fluxes (mmol/gDW/h) for all
the evaluated methods, across all conditions from the Rintala dataset
for S. cerevisiae. All the conditions are sorted by increasing error of
pFBA simulation. The error distribution is individually scaled for
each method. Missing columns represent failed computations.
(TIF)
Figure S4 Transcriptomics vs proteomics. Comparison of
the normalized prediction error for each method across multiple
conditions using either transcriptomic or proteomic data. Two
scenarios are evaluated: prediction of the complete metabolic
phenotype (growth, secretion and intracellular fluxes) from
measured uptake rates (a–d); and prediction of the intracellular
fluxes from the measured physiology (growth, uptake and secretion
rates) (e–h).
(TIF)
Figure S5 Sensitivity analysis (Holm). Sensitivity analysis
of the parameterized methods using the Holm dataset. The
averaged normalized prediction errors across all conditions are
presented.
(TIF)
Figure S6 Sensitivity analysis (Rintala). Sensitivity analysis
of the parameterized methods using the Holm dataset. The
averaged normalized prediction errors across all conditions are
presented.
(TIF)
Figure S7 Robustness analysis (Rintala). Robustness
analysis of the different methods towards increasing levels of noise
in the data. The noise level varies from 0 (original data) to 1
(completely random data). Analysis performed using the anaerobic
condition from the Rintala dataset.
(TIF)
Figure S8 Comparison of the prediction errors for the
original formulation of the methods (a–c) to the scenario
where a minimum growth rate of 90% is enforced for all
methods (d–f). The absence of results for iMAT in the Holm
dataset results from infeasibility of solutions using the imposed
constraints.
(TIF)
Table S1 Original methods validation. Description of the
validation approach and data sources for each method in their
original publication.
(PDF)
Table S2 Compilation of multiomics dataset referenc-
es. Compilation of literature references containing multi-omics
datasets including transcriptomic and fluxomic data for E. coli and
the yeast S. cerevisiae. The datasets used in this study are
highlighted.
(PDF)
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